Invention Grant
- Patent Title: Antagonists of prostaglandin EP3 receptor
- Patent Title (中): 前列腺素EP3受体拮抗剂
-
Application No.: US14506752Application Date: 2014-10-06
-
Publication No.: US09278953B2Publication Date: 2016-03-08
- Inventor: Kevin Barry Bahnck , David James Edmonds , Kentaro Futatsugi , Esther Cheng Yin Lee , Alan Martin Mathiowetz , Elnaz Menhaji-Klotz , Robert Vernon Stanton
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Mary J. Hosley
- Main IPC: C07D213/63
- IPC: C07D213/63 ; A61K31/44 ; C07D401/14
Abstract:
Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.
Public/Granted literature
- US20150099782A1 ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR Public/Granted day:2015-04-09
Information query
